Prostate Cancer Industry Global Market Trends, Share, Size and 2022 Forecast Report

Report Scope:

The scope of this study is testing, screening technology and also therapeutics markets for prostate cancer. The report also includes the regulatory environment, current technologies, new technologies, prostate cancer incidence, market projections and market share, along with latest trends and new developments.

 

Screening for diagnosis, therapy via drug, surgery or radiation is measured and broken down by PSA testing, digital rectal exam (DRE), prostate biopsy, hormone therapy, chemotherapy, immunotherapy, external beam radiation therapy (EBRT), prostatectomy and brachytherapy.

 

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2820037-prevention-and-treatment-of-prostate-cancer-technologies-and-global-markets  

 

Report Includes:

– An overview of the market for the prevention and treatment of prostate cancer, with coverage of the mechanisms of disease development, detection and diagnosis, and anticancer agents

– Analyses of global market trends, with data from 2012, 2016, and projections of compound annual growth rates (CAGRs) through 2021

– Discussion of risk factors, natural history, epidemiology, and the genetics of prostate cancer

– Examinations of prostate-specific antigen (PSA) screening, including the causes of PSA changes, PSA thresholds, and controversies over the screening

– Coverage of emerging therapies, including combination therapy, therapeutic vaccines, inhibitors of kinase signaling pathways, proteasome inhibitors, angiogenesis inhibitors, and immunotherapeutic agents

– Evaluation of prostate cancer treatment products by geography, race, and category

– Breakdown of the industry structure, including market shares, trends in price and price performance, and factors influencing demand

– Comprehensive company profiles of major players in the field.

 

Key Players

ABBOTT LABORATORIES

ACTIVE BIOTECH AB

ALGETA

AMGEN

ASTELLAS PHARMA US

ASTRAZENECA

ATRIX LABORATORIES

BAVARIAN NORDIC A/S

BAYER HEALTHCARE PHARMACEUTICALS

BRISTOL-MYERS SQUIBB

C.R. BARD

CZ BIOMED CORP.

DENDREON CORP.

DIAGNOCURE

EXELIXIS

Exosome Diagnostics

GE HEALTHCARE

GENOMIC HEALTH

GLAXOSMITHKLINE

HOLOGIC

INTUITIVE SURGICAL

MEDIVATION

Metamark

MILLENNIUM PHARMACEUTICALS

MYRIAD GENETICS

NORTHWEST BIOTHERAPEUTICS

ONCOGENEX

OPKO HEALTH

PFIZER

SANOFI

SIEMENS AG

SPECTRUM PHARMACEUTICALS

Varian Medical Systems

 

Table of Content: Key Points

Chapter 1 Introduction

Study goals and objectives

Reasons for doing this study

Intended audience

Scope of report

Information sources

Methodology

Geographic breakdown

Analyst’s credentials

Related BCC Research reports

Chapter 2 Summary and highlights

Chapter 3 Overview

Introduction

U.S. Preventive Services Task Force recommendations

Biology of prostate cancer

Prostate gland

Prostate gland function

Growth of the prostate gland

Types of prostate cancer

…Continued                            

 

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2820037-prevention-and-treatment-of-prostate-cancer-technologies-and-global-markets             

                                 

Contact Info:                                                         

NORAH TRENT                                                      

sales@wiseguyreports.com             

Ph: +1-646-845-9349 (US)                          

Ph: +44 208 133 9349 (UK)                                                   

                                                                             

Get in touch:                                                         

LinkedIn: www.linkedin.com/company/4828928

Twitter: https://twitter.com/WiseGuyReports                                                                  

Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts   

Leave a Reply

Your email address will not be published. Required fields are marked *